Related Experiment Video
Updated: Mar 30, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
[Therapy of psychotic schizophrenia spectrum disorders in adolescents]
Yu V Popov1, Yu A Yakovleva1, M V Pisevich1
1Bekhterev St. Petersburg Psychoneurological Research Institute, St. Petersburg.
Objective:
To assess the clinical efficacy, tolerability and safety of prolonged treatment with paliperidone in adolescents with the exacerbation of psychotic schizophrenia spectrum disorders.
Material And Methods:
Thirty-six adolescents at the age from 14 to 18 years with ICD-10 diagnosis F20-21, F25 were examined by clinical/psychopathological method (PANSS and CGI scale). The duration of the disease was from 1 to 3 years. The duration of the study was 12 months.
Results And Conclusion:
The efficacy and safety of prolonged use of paliperidone in a dose of 3 to 12 mg/day in adolescents with schizophrenia spectrum disorders were identified.
Related Concept Videos
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Psychological and Sociocultural Causes of Schizophrenia
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Schizophrenia

